Date: 2016-07-20
Type of information: Collaboration agreement
Compound: The Angels Initiative
Company: Boehringer Ingelheim (Germany) European Stroke Organisation
Therapeutic area: Cerebrovascular diseases
Type agreement: collaboration
Action mechanism:
Disease: ischaemic stroke
Details: * On July 20, 2016, the European Stroke Organisation and Boehringer Ingelheim have launch the “Angels Initiative”. The European Angels Initiative, which was now launched by the ESO and Boehringer Ingelheim, aims at building a community of at least 1,500 stroke centres andstroke ready hospitals across Europe by May 2019. To achieve this, the initiative will support hospitals and physicians in setting up or improving stroke centres through various measures, which have been developed together with a steering committee of leading stroke experts from around the world. These measures include educational tools and programmes, support for in-hospital process optimization and a community platform for peer-to-peer exchange and access to the world’s leading stroke specialists. Suffering a stroke is one of the most devastating medical emergencies that can happen to a person. It is also a great challenge for the medical personnel treating the patient, trying to save their patients’ life and independence. If patients are treated as quickly as possible and according to best standard of care in dedicated stroke centres, their chances of survival and a disability-free life can be improved dramatically. However, over two thirds of acute stroke patients in Europe are currently not treated in such a dedicated stroke centre. The Angels Initiative, launched by the European Stroke Organisation (ESO) and Boehringer Ingelheim, wants to address this problem to improve stroke care across Europe. The Angels Initiative is fully funded by Boehringer Ingelheim and is part of a broader program with a commitment to add value in stroke care in a holistic way and to ultimately reduce the burden of stroke by improving prevention, diagnosis, and treatment of acute strokes. It builds on the experience from earlier successful implementations of stroke care improvement projects designed and conducted by Boehringer Ingelheim in developing countries, amongst others in the Middle East & North Africa region, India and South Africa. For example, the number of patients in India now receiving acute stroke treatment has increased 3-fold through these improvements.
Financial terms:
Latest news:
